Category: Benjamin Wolozin

Do brain games work?

October 12th, 2014 in 2014, Benjamin Wolozin, Boston Globe, Newsmakers, School of Medicine 0 comments

faculty-wolozin3Boston Globe (subscription required)
Benjamin Wolozin, School of Medicine

The Brain Fit Club looks like any other gym: Hardwood floors gleam under bright lights, a big flat-screen television monitor hangs on the back wall. But some things are different: There are no towels and no mirrors, for instance, and computers perch expectantly on ledges along the wall. Those are the “brain treadmills,” where the heavy mental lifting happens under the steady gaze of personal brain trainer Bonnie Wong…

Expert quote:

“I’ve never heard of anyone wearing out their brain — except on drugs.”

View full article

Alzheimer Researchers See Protein as Target for Drugs

July 16th, 2014 in 2014, Benjamin Wolozin, Bloomberg, Newsmakers, School of Medicine 0 comments

faculty-wolozin3Bloomberg
Benjamin Wolozin, School of Medicine, Alzheimer’s Disease Center

A protein discovered less than a decade ago appears to play a role in whether symptoms of Alzheimer’s disease emerge, suggesting another avenue for exploration in efforts to find a treatment…

Expert quote:

“This is beginning to present the case that actually TDP-43 is a major player in the cognitive loss associated with Alzheimer’s disease.”

View full article

Diabetes Drug Shows Slight Effect on Dementia in German Study

July 14th, 2014 in 2014, Benjamin Wolozin, Bloomberg, Centers & Institutes in the News, Newsmakers, School of Medicine 0 comments

faculty-wolozin3Bloomberg
Benjamin Wolozin, School of Medicine, Alzheimer’s Disease Center

Older Germans who took Takeda Pharmaceutical Co. (4502)’s diabetes medicine Actos were slightly less likely to develop dementia, according to a study that may do little to resolve questions about the drug’s usefulness…

Expert quote:

“It was very important to do this study. However, it’s actually almost surprising to me that the lowering of relative risk was so weak.”

View full article

Statins tied to slightly lower risk of Parkinson’s

March 14th, 2012 in 2012, Benjamin Wolozin, Newsmakers, Reuters, School of Medicine 0 comments

Reuters
Benjamin Wolozin, School of Medicine

People taking statins have a slightly lower risk of developing Parkinson’s disease than those not on the cholesterol-lowering drugs, suggests a new study…

View article